Cephasonics Ultrasound is an ISO 13485-certified OEM provider of advanced ultrasound platforms for medical device manufacturers and innovators developing next-generation imaging, robotics, navigation, therapeutic ultrasound, quantitative ultrasound, and AI-enabled healthcare solutions. Guided by its vision of Ultrasound Intelligence™, Cephasonics enables customers to transform ultrasound from a standalone imaging modality into an integrated source of real-time data, measurement, and decision support. The company’s scalable ultrasound technology, open software architecture, and development platforms allow customers to rapidly integrate ultrasound into their products while maintaining complete control over their application, workflow, and user experience. A key differentiator is Cephasonics’ focus on interoperability, enabling ultrasound to seamlessly connect with robotic systems, navigation technologies, AI engines, therapeutic devices, sensors, and third-party medical technologies. At IUS 2026, Cephasonics will showcase its next-generation Tahoe™ platform, featuring higher performance, reduced size and power consumption, flexible software, support for advanced ultrasound modalities, and real-time access to ultrasound RF channel data. The company will also demonstrate its Ultrasound Server™ architecture, which enables ultrasound to operate as an interoperable real-time data service shared across multiple applications, devices, and software systems. By combining advanced ultrasound technology, open integration, and ISO 13485-certified development and manufacturing, Cephasonics helps innovators accelerate development, reduce commercialization risk, and bring differentiated ultrasound-enabled medical devices to market.
